Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events

Documenti analoghi

• Navigating Drug–Drug Interactions in Clinical Drug Development: A Tutorial
  di: Jesmin Lohy Das, et al.
  Pubblicazione: (2025)
• Clinical Evaluation of Drug–Drug Interactions With Aficamten
  di: Neha Maharao, et al.
  Pubblicazione: (2026)
• Clinical Significance of Drug–Drug Interaction Studies During Therapeutic Peptide Drug Development: Follow‐Up Investigation of Therapeutic Peptides Approved Between 2021 and 2024
  di: Carolina Säll, et al.
  Pubblicazione: (2025)
• Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists
  di: Mariam A. Ahmed, et al.
  Pubblicazione: (2025)
• Tutorial Drug–Drug Interactions
  di: Edward M. Sellers
  Pubblicazione: (2025)